620
Views
9
CrossRef citations to date
0
Altmetric
Short Communication

PrPSc-specific antibodies do not induce prion disease or misfolding of PrPC in highly susceptible Tga20 mice

, , , , , , & show all
Pages 434-439 | Received 13 Aug 2013, Accepted 26 Sep 2013, Published online: 08 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jennifer T Burchell & Peter K Panegyres. (2016) Prion diseases: immunotargets and therapy. ImmunoTargets and Therapy 5, pages 57-68.
Read now
Ryan Taschuk, Jacques Van der Merwe, Kristen Marciniuk, Andrew Potter, Neil Cashman, Philip Griebel & Scott Napper. (2015) In vitro neutralization of prions with PrPSc-specific antibodies. Prion 9:4, pages 292-303.
Read now
Ryan Taschuk, Kristen Marciniuk, Pekka Määttänen, Claudia Madampage, Peter Hedlin, Andrew Potter, Jeremy Lee, Neil R. Cashman, Philip J Griebel & Scott Napper. (2014) Safety, specificity and immunogenicity of a PrPSc-specific prion vaccine based on the YYR disease specific epitope. Prion 8:1, pages 51-59.
Read now

Articles from other publishers (6)

Scott Napper & Hermann M. Schatzl. (2023) Oral vaccination as a potential strategy to manage chronic wasting disease in wild cervid populations. Frontiers in Immunology 14.
Crossref
Scott Napper & Hermann M. Schatzl. (2023) Vaccines for prion diseases: a realistic goal?. Cell and Tissue Research 392:1, pages 367-392.
Crossref
Akanksha Baharani, Zelan Wei, William J. Roesler & Darrell D. Mousseau. (2020) A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington’s Disease: Possible Sex-Dependent Signaling. Cellular and Molecular Neurobiology 42:3, pages 871-888.
Crossref
Gianluigi Forloni, Ignazio Roiter & Fabrizio Tagliavini. (2019) Clinical trials of prion disease therapeutics. Current Opinion in Pharmacology 44, pages 53-60.
Crossref
Mary E. Wood, Philip Griebel, Matthew L. Huizenga, Samuel Lockwood, Cole Hansen, Andrew Potter, Neil Cashman, John W. Mapletoft & Scott Napper. (2018) Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrPSc-specific vaccine and housed in a prion contaminated environment. Vaccine 36:50, pages 7737-7743.
Crossref
Kristen Marciniuk, Ryan Taschuk & Scott Napper. 2016. Vaccine Design. Vaccine Design 657 680 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.